ResInsights Live

Online Events

Pulmonary Arterial Hypertension

  • CME
    1.0

    Evolutionary Approaches to the Patient with Pulmonary Arterial Hypertension

    Speakers:Harrison W. Farber, MD, FAHA, FCCP, Professor of Medicine, Pulmonary Hypertension Center

    Duration: 60 minutes

    Presented on: June 28, 2016

Speakers

Pulmonary Arterial Hypertension

  • Harrison W. Farber, MD, FAHA, FCCP

    Harrison W. Farber, MD, FAHA, FCCP

    Harrison W. Farber, MD, FAHA, FCCP

    Professor of Medicine, Pulmonary Hypertension Center

    Harrison W. Farber, MD, is Professor of Medicine and Director of the Pulmonary Hypertension Center at Boston University/Boston Medical Center. With a research focus on endothelial cell biology, his laboratory is investigating the response of the pulmonary vasculature in different etiologies of pulmonary hypertension using genomic and proteomic approaches to identify unique molecules as potential targets for new therapies for pulmonary hypertension associated with sickle cell disease, scleroderma, and left ventricular diastolic dysfunction. Dr Farber is an NIH-funded principle investigator on numerous grants, and is a member of several research groups both within the Pulmonary Hypertension Center and other divisions within the Department of Medicine.

All Speakers

  • Harrison W. Farber, MD, FAHA, FCCP

    Harrison W. Farber, MD, FAHA, FCCP

    Harrison W. Farber, MD, FAHA, FCCP

    Professor of Medicine, Pulmonary Hypertension Center

    Harrison W. Farber, MD, is Professor of Medicine and Director of the Pulmonary Hypertension Center at Boston University/Boston Medical Center. With a research focus on endothelial cell biology, his laboratory is investigating the response of the pulmonary vasculature in different etiologies of pulmonary hypertension using genomic and proteomic approaches to identify unique molecules as potential targets for new therapies for pulmonary hypertension associated with sickle cell disease, scleroderma, and left ventricular diastolic dysfunction. Dr Farber is an NIH-funded principle investigator on numerous grants, and is a member of several research groups both within the Pulmonary Hypertension Center and other divisions within the Department of Medicine.
 

Partners

Academic

  • logo-einstein

Associations

Publishers